Neuroleptic malignant syndrome
- 1 January 1984
- journal article
- case report
- Published by AMPCo in The Medical Journal of Australia
- Vol. 140 (1) , 28-30
- https://doi.org/10.5694/j.1326-5377.1984.tb103843.x
Abstract
Three cases of the neuroleptic malignant syndrome, which complicated treatment with haloperidol, fluphenazine and, in one case, with several drugs, are described. All three patients recovered and, in two, levodopa appeared to modify the course of the condition. In one patient, myoclonus was present and has persisted. The pharmacological mechanisms involved in this syndrome are discussed.Keywords
This publication has 12 references indexed in Scilit:
- Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case reportAmerican Journal of Psychiatry, 1982
- Neuroleptic Malignant syndrome caused by dopamine‐depleting drugs in a patient with Huntington diseaseNeurology, 1981
- Neuroleptic malignant syndromeNeurology, 1981
- Neuroleptic Malignant SyndromeArchives of Neurology, 1980
- Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptorsNature, 1980
- The pathophysiology of extrapyramidal side-effects of neuroleptic drugsPsychological Medicine, 1980
- CLINICAL, BIOCHEMICAL, AND PHYSIOLOGICAL FEATURES DISTINGUISHING MYOCLONUS RESPONSIVE TO 5-HYDROXYTRYPTOPHAN, TRYPTOPHAN WITH A MONOAMINE OXIDASE INHIBITOR, AND CLONAZEPAMBrain, 1977
- THE CATATONIC SYNDROMEThe Lancet, 1976
- Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine NeuronsScience, 1975
- The role of serotonin in the pathophysiology of myoclonic seizures associated with acute imipramine toxicityNeurology, 1974